FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4297154080> ?p ?o ?g. }

• W4297154080 abstract "Background Poor prognosis, resistance to chemotherapy, insensitivity to radiotherapy, and a high prevalence of adverse drug reactions remain urgent issues for breast cancer (BC) patients. Increased knowledge of tumor immunobiology and vaccine development suggests the possibility of cancer vaccination. Here, we investigated potential BC-associated antigens for the development of an anti-BC mRNA vaccine and populations suitable for mRNA vaccination. Methods Gene expression and clinical data were obtained from The Cancer Genome Atlas (TCGA) and Molecular Taxonomy of Breast Cancer International Consortium (METABRIC). The single-cell sequencing data were obtained from the Single Cell Portal platform. cBioPortal was used to visualize and compare genetic alterations. Correlations between immune cell infiltration and antigen expression were visualized with the Tumor Immune Estimation Resource (TIMER). Immune subtypes were identified by consensus clustering and analysis of immune infiltration. Biomarkers for the assessment of mRNA vaccination suitability were investigated. Results Three tumor-associated antigens, CD74, IRF1, and PSME2, that showed overexpression, amplification, and mutation and were linked with prognosis and immune cell infiltration, were identified. Single-cell sequencing analysis showed the expression of the three tumor-associated antigens in different cells of BC. Three immune subtypes were identified among BC patients, with Cluster B patients having a tumor microenvironment conducive to immunotherapy. These subtypes also showed different expression patterns of immune checkpoints, immune cell death-promoting genes, and response to immune checkpoint inhibitor (ICI) therapy. Thus, we identified five biomarkers that could be applied for assessing vaccination suitability and predicted drugs that would be appropriate for patients unsuited for vaccination. Conclusions Our findings suggest new directions for the development of mRNA vaccines against breast cancer." @default.
• W4297154080 created "2022-09-27" @default.
• W4297154080 creator A5016251217 @default.
• W4297154080 creator A5032599698 @default.
• W4297154080 creator A5046597133 @default.
• W4297154080 creator A5046760664 @default.
• W4297154080 creator A5052803150 @default.
• W4297154080 creator A5054386725 @default.
• W4297154080 creator A5076699095 @default.
• W4297154080 date "2022-09-26" @default.
• W4297154080 modified "2023-10-17" @default.
• W4297154080 title "Identification of tumor antigens and immune subtypes in breast cancer for mRNA vaccine development" @default.
• W4297154080 cites W1546040549 @default.
• W4297154080 cites W1966327575 @default.
• W4297154080 cites W1967009979 @default.
• W4297154080 cites W1983724622 @default.
• W4297154080 cites W1984619541 @default.
• W4297154080 cites W1985987855 @default.
• W4297154080 cites W2003442857 @default.
• W4297154080 cites W2035618305 @default.
• W4297154080 cites W2036011198 @default.
• W4297154080 cites W2049553585 @default.
• W4297154080 cites W2075294566 @default.
• W4297154080 cites W2108068107 @default.
• W4297154080 cites W2110014529 @default.
• W4297154080 cites W2115182182 @default.
• W4297154080 cites W2115462905 @default.
• W4297154080 cites W2130410032 @default.
• W4297154080 cites W2147881852 @default.
• W4297154080 cites W2149441684 @default.
• W4297154080 cites W2159707944 @default.
• W4297154080 cites W2171015116 @default.
• W4297154080 cites W2179056957 @default.
• W4297154080 cites W2214074259 @default.
• W4297154080 cites W2302634809 @default.
• W4297154080 cites W2337944657 @default.
• W4297154080 cites W2345415641 @default.
• W4297154080 cites W2560367415 @default.
• W4297154080 cites W2595349270 @default.
• W4297154080 cites W2744067212 @default.
• W4297154080 cites W2761007430 @default.
• W4297154080 cites W2769547311 @default.
• W4297154080 cites W2774223113 @default.
• W4297154080 cites W2796207838 @default.
• W4297154080 cites W2800948756 @default.
• W4297154080 cites W2896872272 @default.
• W4297154080 cites W2902652978 @default.
• W4297154080 cites W2912993657 @default.
• W4297154080 cites W2927937021 @default.
• W4297154080 cites W2943180760 @default.
• W4297154080 cites W2982314248 @default.
• W4297154080 cites W2987417623 @default.
• W4297154080 cites W2995882574 @default.
• W4297154080 cites W2997835149 @default.
• W4297154080 cites W2998563599 @default.
• W4297154080 cites W2999417355 @default.
• W4297154080 cites W3011204118 @default.
• W4297154080 cites W3012668557 @default.
• W4297154080 cites W3014160477 @default.
• W4297154080 cites W3027286012 @default.
• W4297154080 cites W3091061098 @default.
• W4297154080 cites W3130729977 @default.
• W4297154080 cites W3134481517 @default.
• W4297154080 cites W3139530191 @default.
• W4297154080 cites W3150385600 @default.
• W4297154080 cites W3164692211 @default.
• W4297154080 cites W3176889573 @default.
• W4297154080 cites W3202007017 @default.
• W4297154080 cites W4200380160 @default.
• W4297154080 cites W4225263876 @default.
• W4297154080 doi "https://doi.org/10.3389/fonc.2022.973712" @default.
• W4297154080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36226063" @default.
• W4297154080 hasPublicationYear "2022" @default.
• W4297154080 type Work @default.
• W4297154080 citedByCount "3" @default.
• W4297154080 countsByYear W42971540802022 @default.
• W4297154080 countsByYear W42971540802023 @default.
• W4297154080 crossrefType "journal-article" @default.
• W4297154080 hasAuthorship W4297154080A5016251217 @default.
• W4297154080 hasAuthorship W4297154080A5032599698 @default.
• W4297154080 hasAuthorship W4297154080A5046597133 @default.
• W4297154080 hasAuthorship W4297154080A5046760664 @default.
• W4297154080 hasAuthorship W4297154080A5052803150 @default.
• W4297154080 hasAuthorship W4297154080A5054386725 @default.
• W4297154080 hasAuthorship W4297154080A5076699095 @default.
• W4297154080 hasBestOaLocation W42971540801 @default.
• W4297154080 hasConcept C121608353 @default.
• W4297154080 hasConcept C126322002 @default.
• W4297154080 hasConcept C147483822 @default.
• W4297154080 hasConcept C203014093 @default.
• W4297154080 hasConcept C22070199 @default.
• W4297154080 hasConcept C2776107976 @default.
• W4297154080 hasConcept C2776624504 @default.
• W4297154080 hasConcept C2777701055 @default.
• W4297154080 hasConcept C2778378633 @default.
• W4297154080 hasConcept C2780674031 @default.
• W4297154080 hasConcept C502942594 @default.
• W4297154080 hasConcept C530470458 @default.
• W4297154080 hasConcept C71924100 @default.
• W4297154080 hasConcept C86803240 @default.

• next